CAR-NK Revolution: Engineered Natural Killer Cells Outperform CAR-T in Safety, Paving the Way for Mainstream Adoption in Cancer Treatment
Chimeric Antigen Receptor (CAR) technology, once synonymous with T-cell therapies, is now transforming natural killer (NK) cells into a promising frontier. CAR-NK cells, engineered to express tumor-targeting receptors, combine the precision of CAR-T with NK cells’ inherent safety profile—marking a potential paradigm shift in cancer treatment. Clinical trials for CAR-NK therapies in...
0 Σχόλια 0 Μοιράστηκε 57 Views 0 Προεπισκόπηση